Drug Shortage Report for VALSARTAN
| Report ID | 55158 |
| Drug Identification Number | 02384558 |
| Brand name | VALSARTAN |
| Common or Proper name | VALSARTAN |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | VALSARTAN |
| Strength(s) | 160MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2018-07-10 |
| Estimated end date | Unknown |
| Actual end date | 2021-08-16 |
| Shortage status | Resolved |
| Updated date | 2021-08-17 |
| Company comments | Temporarily unavailable |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-08-17 | English | Compare |
| v5 | 2021-08-16 | French | Compare |
| v4 | 2021-08-16 | English | Compare |
| v3 | 2018-07-11 | English | Compare |
| v2 | 2018-07-10 | French | Compare |
| v1 | 2018-07-10 | English | Compare |
Showing 1 to 6 of 6